Creative Biolabs-Lipid Based Drug Delivery

Phospholipid

The development of drug delivery systems allows for a significant improvement of the efficiency of drug applications. Today, many ready-made drug forms based on different delivery systems have been introduced into medicine. Among them, phospholipid-based carriers have received great attention because of their high biocompatibility and ability to encapsulate a large number of pharmaceuticals inside the vesicle. Therefore, these drug formulations are highly popular in the pharmaceutical market and are much in demand in the drug market

Background of Phospholipid

Phospholipids (PLs) are highly specialized lipids that are major constituents of cellular membranes of all variety of living organisms and play a crucial role in the biochemistry and physiology of the cell. As an amphipathic molecule, PL possesses a positively charged headgroup and two neutrally charged tail groups. This is a rare molecular characteristic that renders PLs miscible in both water and lipid environments, in which the oxygen atoms of the phosphate group have a strong tendency to obtain electrons, while the nitrogen atoms have a strong tendency to lose electrons. In addition, any kind of drug possessing an active hydrogen atom (−COOH, −OH, −NH2, −NH−, =NH, etc.) can be esterified (with or without spacer chain) to the hydroxyl group of a PLs molecule, generating an amphiphilic agent to facilitate the crossing of the cell membrane barrier. Therefore, PLs is considered to be an extremely attractive delivery vehicle. For example, the building material of some nanoparticles can be used in certain drug molecules to enhance absorption across lipid-rich biological barriers and increase drug efficacy, thereby improving therapeutic effects.

Classification of Phospholipid

Phospholipids consist of a glycerol backbone and a phosphate head group, which is typically located at the sn-3 position (Fig. 1). The simplest phospholipid is phosphatidic acid (PA) and other phospholipids are named according to the group attached to the phosphate group. For example, if the group attached to the phosphate group is choline, this phospholipid is named phosphatidylcholine (PC). Other substituents on the phosphate group include ethanolamine, serine and inositol, thus these phospholipids are respectively called phosphatidylethanolamine (PE), phosphatidylserine (PS) and phosphatidylinositol (PI). Lysophospholipids refer to phospholipids whose fatty acid chain has been removed from the sn-1 or sn-2 position. In addition, there is another type of lipids, sphingolipids, which are sometimes considered to be phospholipids because they may contain a phosphatidylcholine or phosphatidylethanolamine group in the molecules, for example, sphingomyelin contains a phosphatidylethanolamine group.

Fig.1 Miscellaneous types. (Creative Biolabs Original)Fig.1 The structures and shape of phospholipids.

The Application of Phospholipid

The phospholipid systems can encapsulate hydrophilic molecules in an aqueous core and embed lipophilic drugs in a lipid bilayer membrane. In recent years, many hundreds of drugs, including anticancer and antimicrobial agents, chelating agents, peptide hormones, enzymes, proteins, vaccines and genetic materials, have been incorporated into the aqueous or lipid phases of liposomes, with various sizes, compositions and other characteristics. Thus, the system provides selective delivery of various biomolecules to a target site for in vivo application

What We Can Do about Phospholipid?

With years of experience and advanced drug development platforms, Creative Biolabs provides several types of drug formulations based on phytosomes by relatively easy-to-fabricate preparation strategies using amphiphilic nanoparticles. If you have any needs in this regard, please contact us as soon as possible.

For Research Use Only. Not For Clinical Use

Supports

Formulation Science Background of Liposome Research Highlights
Resources Technical Supports Featured Services Knowledge Center
Optimizing LNP Molar Ratios for Transfection Efficiency
Scalability Challenges in mRNA-LNP Manufacturing
Beyond mRNA: LNP Delivery for CRISPR/Cas9
Cationic Lipids Evolution: DOTAP to Ionizable Lipids
LNP Storage Stability: Lyophilization vs. Liquid
Modulating LNP Biodistribution: Overcoming Liver Accumulation
Active vs. Passive Targeting (EPR): A Guide to Tumor Drug Delivery
Immunoliposomes: Comparing Pre-insertion vs. Post-insertion Techniques
Crossing the BBB: Advances in Transferrin and Peptide-Modified Liposomes
pH-Responsive Liposomes for Tumor Microenvironment
Thermosensitive Liposomes combined with HIFU
Aptamer-Modified Liposomes: A Cost-Effective Antibody Alternative
Ethosomes vs Transfersomes for Dermal Delivery
Strategies for Encapsulating Poorly Water-Soluble Small Molecules in Liposomes
Multivesicular Liposomes: The Architecture of Sustained Release
Mechanisms of Liposomal Adjuvants in Enhancing Vaccine Immune Response
Protecting Enzymatic Activity: Liposomal Encapsulation Strategies for Enzymes
Cryo-TEM vs. DLS: Interpreting Discrepancies in Liposome Particle Size Data
Validating In Vitro Release Methods: Dialysis vs. Sample Separation Techniques
Predicting Long-Term Stability of Liposomal Suspensions using Zeta Potential
Troubleshooting Low Liposome Encapsulation Efficiency
Application of Multi-omics Analysis in Liposome Toxicology Assessment
The Ultimate Guide to Liposome Preparation
Fluorescent Liposomes for Cellular Uptake: Labeling, Controls, and Troubleshooting
How to Design Stealth Liposomes for Long Circulation
Homemade vs. Commercial Kits: Why Standardization Matters in Liposome Research

Online Inquiry